Follow this preprint
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
View ORCID ProfileChristian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, Hanne-Dorthe Emborg, Tyra Grove Krause, Kåre Mølbak, Palle Valentiner-Branth on behalf of the Infectious Disease Preparedness Group at Statens Serum Institut
doi: https://doi.org/10.1101/2021.12.20.21267966
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Christian Holm Hansen
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
PhDAstrid Blicher Schelde
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
PhDIda Rask Moustsen-Helm
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
PhDHanne-Dorthe Emborg
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
PhDTyra Grove Krause
2Epidemiological Infectious Diseases Preparedness Statens Serum Institut, Copenhagen, Denmark
PhDKåre Mølbak
2Epidemiological Infectious Diseases Preparedness Statens Serum Institut, Copenhagen, Denmark
DMScPalle Valentiner-Branth
1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
PhDArticle usage
Picked up by 67 news outlets
Blogged by 10
Referenced in 5 policy documents
Tweeted by 36487
On 4 Facebook pages
On 2 videos
Posted December 22, 2021.
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, Hanne-Dorthe Emborg, Tyra Grove Krause, Kåre Mølbak, Palle Valentiner-Branth
medRxiv 2021.12.20.21267966; doi: https://doi.org/10.1101/2021.12.20.21267966
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (3002)
- Dermatology (256)
- Emergency Medicine (449)
- Epidemiology (12900)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4698)
- Geriatric Medicine (432)
- Health Economics (742)
- Health Informatics (2986)
- Health Policy (1081)
- Hematology (399)
- HIV/AIDS (942)
- Medical Education (439)
- Medical Ethics (116)
- Nephrology (481)
- Neurology (4486)
- Nursing (239)
- Nutrition (657)
- Oncology (2329)
- Ophthalmology (659)
- Orthopedics (262)
- Otolaryngology (330)
- Pain Medicine (290)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1218)
- Primary Care Research (509)
- Public and Global Health (7073)
- Radiology and Imaging (1570)
- Respiratory Medicine (933)
- Rheumatology (454)
- Sports Medicine (390)
- Surgery (497)
- Toxicology (62)
- Transplantation (214)
- Urology (187)